Articles

Brownstone Journal Articles, News, Research, and Commentary on public health, science, economics, & social theory

Brownstone Institute » Articles
The Full Risk–Benefit Balance Behind the First Covid-19 Vaccine

The Full Risk–Benefit Balance Behind the First Covid-19 Vaccine

SHARE | PRINT | EMAIL

The FDA’s first EUA for a Covid-19 vaccine rested on its determination that the benefits of the Pfizer–BioNTech vaccine outweighed its risks. Yet the trial report did not bring those together within a common framework. I did—and what I found was startling.

The Full Risk–Benefit Balance Behind the First Covid-19 Vaccine Continue Reading

Join 30,000+ Independent Readers: Get the FREE Brownstone Journal Newsletter